Markets:

Overview

News

Currencies

International

Treasuries

iShares Global Healthcare ETF (NY:IXJ)

98.55 +0.17 (+0.17%)

Streaming Delayed Price Updated: 11:20 AM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Global Healthcare ETF

< Previous 1 2 Next >

Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value? ↗

June 26, 2026

Compare global reach to domestic focus as these two funds reveal key differences in cost, risk, and portfolio makeup for healthcare investors.

Via The Motley Fool

Topics ETFs

U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ ↗

June 01, 2026

The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S....

Via The Motley Fool

Topics ETFs Intellectual Property

GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. ↗

May 27, 2026

A closer look at portfolio makeup, yield, and risk reveals what sets these two iShares healthcare funds apart for investors seeking sector exposure.

Via The Motley Fool

Topics ETFs

Janux Stock Is Rising Pre-Market After A New Oncology Deal With Bristol Myers Squibb ↗

January 22, 2026

Via Stocktwits

Trump Steps Up Pressure On Trading Partners Over Drug Costs, Plans Section 301 Review: Report ↗

October 22, 2025

Via Stocktwits

Topics Government

Trump Walks Back Plan To Slap Tariffs On Generic Drugs After White House Clash Over Prices, Supply Risks: Report ↗

October 08, 2025

Via Stocktwits

Topics Government

PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem ↗

May 27, 2026

A concentrated pharma focus sets VanEck apart from iShares’ broader healthcare approach. See how portfolio differences shape risk and income profiles.

Via The Motley Fool

Topics ETFs

INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally? ↗

January 26, 2026

According to a Calcalist report, the company is set to go private after a $1.1 billion acquisition by a fund.

Via Stocktwits

Topics Artificial Intelligence

Why Did Corcept Therapeutics Stock Surge Over 14% Today? ↗

January 22, 2026

In the ROSELLA trial, patients receiving relacorilant with nab-paclitaxel saw their risk of death drop by about 35% compared with those given the chemotherapy alone.

Via Stocktwits

Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗

January 14, 2026

On Tuesday, the company provided the revenue outlook for 2026 and fourth-quarter (Q4) and fiscal year 2025 revenue projection for BRIUMVI.

Via Stocktwits

Topics Artificial Intelligence

CDC In Crisis: Kennedy Pressured To Quit As States Revolt Over Vaccine Board Shake-Up ↗

September 03, 2025

Via Stocktwits

Trump’s Big Pharma Tariff Call Delayed Again As White House Juggles Trade Battles And Diplomatic Showdowns: Report ↗

August 13, 2025

Via Stocktwits

Topics Government

Trump Plans Gradual Tariff Hike On Imported Pharma To 250% Over 18 Months To Boost US Production ↗

August 05, 2025

Via Stocktwits

Topics Government

Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul ↗

December 12, 2025

Via MarketBeat

Trump Admin Targets Medicaid Spending On Immigrants, Threatening Over $12 Billion California Program ↗

September 06, 2025

The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse in immigrant healthcare programs.

Via Benzinga

Topics Government

Trump Pollster Quietly Tells Republicans: Voters Still Trust Childhood Vaccines, Doubt COVID Shots ↗

September 03, 2025

The Fabrizio Ward survey of 1,000 voters found 77% of Trump supporters back measles shots and 69% support hepatitis B, while at least 90% of Kamala Harris voters backed all three vaccines.

Via Stocktwits

Topics ETFs Government

Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca ↗

August 05, 2025

Via Stocktwits

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

RFK Jr. Said To Be Planning Another Health Panel Shakeup — This Time Targeting Preventive Care ↗

July 29, 2025

Via Stocktwits

Trump Overrode RFK Jr. And Makary To Remove FDA Biologics Chief Amid Sarepta Drug Controversy: Report ↗

July 31, 2025

The Trump administration is reportedly considering a major restructuring of the FDA’s biologics division, potentially splitting it into separate offices for vaccines and therapeutics.

Via Stocktwits

Topics Death ETFs Government

Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)

July 29, 2025

In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at...

Via MarketMinute

Topics ETFs Economy

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

AbbVie Stock Nears 3-Month High on Q4 Beat As Immunology Growth Eases Humira Slump: Retail Mood Brightens ↗

January 31, 2025

The company raised its long-term sales outlook for Skyrizi and Rinvoq, now expecting combined revenue of about $24 billion in 2025.

Via Stocktwits

J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient ↗

January 22, 2025

During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually.

Via Stocktwits

Topics Earnings

World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements ↗

January 22, 2025

Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate.

Via Benzinga

Topics Government

Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings

August 09, 2024

Novo Nordisk fell over 8% after its earnings release but recovered nearly all of those losses the next day. It needs to increase supplies of semaglutide.

Via MarketBeat

Topics ETFs

Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy ↗

June 22, 2024

You don't need to be a stock market expert to earn above-average returns.

Via The Motley Fool

Top ETFs for Every Sector ↗

February 22, 2024

Top ETFs for all 11 S&P 500 sectors.

Via The Motley Fool

Topics ETFs Stocks

Market Mayhem: 3 ETFs to Anchor Your Investments in 2024 ↗

January 10, 2024

The top ETFs for 2024 are thematic or sector-specific tickers with upside, presenting market-beating opportunities.

Via InvestorPlace

Topics ETFs

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.